Betty Chang
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Phagocytosis and Immune Regulation, Monoclonal and Polyclonal Antibodies Research, Galectins and Cancer Biology
Most-Cited Works
- → Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia(2013)2,236 cited
- → A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology(2008)1,988 cited
- → Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma(2013)1,669 cited
- → The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy(2010)1,520 cited
- → Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib(2014)1,240 cited
- → Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies(2012)1,110 cited
- → Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma(2015)1,102 cited
- → Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes(2013)787 cited
- → Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome(2010)695 cited
- → Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional Network(2011)551 cited